GE HealthCare Technologies Financial Statements
NASDAQ: GEHCHealth CareMedical ElectronicsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
GE HealthCare Technologies revenue and earnings
In fiscal 2025, GE HealthCare Technologies generated $20.63 billion in revenue, up 4.8% from fiscal 2024, its 4th consecutive year of revenue growth. Net income was $2.08 billion (+4.6% year over year), for a net margin of 10.1% versus a median of 10.3% in the prior 4 years. Gross margin was 40.0% (down from 41.7%) and operating margin 13.4%.
Diluted earnings per share came in at $4.55, up from $4.34. Over the last 4 fiscal years, GEHC's revenue has grown at a 4.1% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
GE HealthCare Technologies income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 |
|---|---|---|---|---|---|
| Revenue | 20.63B | 19.67B | 19.55B | 18.34B | 17.59B |
| Revenue growth (YoY) | +4.84% | +0.61% | +6.60% | +4.30% | — |
| Gross Profit | 8.25B | 8.21B | 7.92B | 7.18B | 7.17B |
| Operating Expenses | 5.49B | 5.58B | 5.49B | 4.66B | 4.38B |
| Research & Development | 1.26B | 1.31B | 1.21B | 1.03B | 816.00M |
| Selling, General & Admin | 4.22B | 4.27B | 4.28B | 3.63B | 3.56B |
| Operating Income | 2.76B | 2.63B | 2.44B | 2.52B | 2.79B |
| Interest Expense | 440.00M | 504.00M | 542.00M | 77.00M | 40.00M |
| Other Income (Expense) | 157.00M | 55.00M | 86.00M | 62.00M | 123.00M |
| Pretax Income | 2.77B | 2.58B | 2.36B | 2.51B | 2.88B |
| Income Tax | 614.00M | 531.00M | 743.00M | 563.00M | 600.00M |
| Net Income | 2.08B | 1.99B | 1.57B | 1.92B | 2.25B |
| Net Income growth (YoY) | +4.57% | +27.10% | -18.16% | -14.73% | — |
| EPS (Basic) | 4.56 | 4.37 | 3.05 | 4.22 | 4.95 |
| EPS (Diluted) | 4.55 | 4.34 | 3.03 | 4.22 | 4.95 |
| Shares Outstanding (Basic) | 456.00M | 456.00M | 455.00M | 454.00M | 454.00M |
| Shares Outstanding (Diluted) | 458.00M | 459.00M | 458.00M | 454.00M | 454.00M |
| EBITDA | 3.05B | 2.89B | 2.68B | 2.75B | 3.02B |
| Gross Margin | 39.99% | 41.71% | 40.52% | 39.14% | 40.80% |
| Operating Margin | 13.40% | 13.34% | 12.45% | 13.75% | 15.89% |
| Net Margin | 10.10% | 10.13% | 8.02% | 10.45% | 12.78% |
This table shows 5 annual periods of GE HealthCare Technologies's income statement, from FY 2025 back to FY 2021, across 19 line items including revenue, gross profit, operating expenses. Values in USD; B = billions, M = millions. Fiscal periods follow GEHC's reporting calendar. What is a income statement?